Cargando…

Commercial and Scientific Solutions for Blood Glucose Monitoring—A Review

Diabetes is a chronic and, according to the state of the art, an incurable disease. Therefore, to treat diabetes, regular blood glucose monitoring is crucial since it is mandatory to mitigate the risk and incidence of hyperglycemia and hypoglycemia. Nowadays, it is common to use blood glucose meters...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Yirui, Thalmayer, Angelika S., Zeising, Samuel, Fischer, Georg, Lübke, Maximilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780031/
https://www.ncbi.nlm.nih.gov/pubmed/35062385
http://dx.doi.org/10.3390/s22020425
_version_ 1784637729412218880
author Xue, Yirui
Thalmayer, Angelika S.
Zeising, Samuel
Fischer, Georg
Lübke, Maximilian
author_facet Xue, Yirui
Thalmayer, Angelika S.
Zeising, Samuel
Fischer, Georg
Lübke, Maximilian
author_sort Xue, Yirui
collection PubMed
description Diabetes is a chronic and, according to the state of the art, an incurable disease. Therefore, to treat diabetes, regular blood glucose monitoring is crucial since it is mandatory to mitigate the risk and incidence of hyperglycemia and hypoglycemia. Nowadays, it is common to use blood glucose meters or continuous glucose monitoring via stinging the skin, which is classified as invasive monitoring. In recent decades, non-invasive monitoring has been regarded as a dominant research field. In this paper, electrochemical and electromagnetic non-invasive blood glucose monitoring approaches will be discussed. Thereby, scientific sensor systems are compared to commercial devices by validating the sensor principle and investigating their performance utilizing the Clarke error grid. Additionally, the opportunities to enhance the overall accuracy and stability of non-invasive glucose sensing and even predict blood glucose development to avoid hyperglycemia and hypoglycemia using post-processing and sensor fusion are presented. Overall, the scientific approaches show a comparable accuracy in the Clarke error grid to that of the commercial ones. However, they are in different stages of development and, therefore, need improvement regarding parameter optimization, temperature dependency, or testing with blood under real conditions. Moreover, the size of scientific sensing solutions must be further reduced for a wearable monitoring system.
format Online
Article
Text
id pubmed-8780031
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87800312022-01-22 Commercial and Scientific Solutions for Blood Glucose Monitoring—A Review Xue, Yirui Thalmayer, Angelika S. Zeising, Samuel Fischer, Georg Lübke, Maximilian Sensors (Basel) Review Diabetes is a chronic and, according to the state of the art, an incurable disease. Therefore, to treat diabetes, regular blood glucose monitoring is crucial since it is mandatory to mitigate the risk and incidence of hyperglycemia and hypoglycemia. Nowadays, it is common to use blood glucose meters or continuous glucose monitoring via stinging the skin, which is classified as invasive monitoring. In recent decades, non-invasive monitoring has been regarded as a dominant research field. In this paper, electrochemical and electromagnetic non-invasive blood glucose monitoring approaches will be discussed. Thereby, scientific sensor systems are compared to commercial devices by validating the sensor principle and investigating their performance utilizing the Clarke error grid. Additionally, the opportunities to enhance the overall accuracy and stability of non-invasive glucose sensing and even predict blood glucose development to avoid hyperglycemia and hypoglycemia using post-processing and sensor fusion are presented. Overall, the scientific approaches show a comparable accuracy in the Clarke error grid to that of the commercial ones. However, they are in different stages of development and, therefore, need improvement regarding parameter optimization, temperature dependency, or testing with blood under real conditions. Moreover, the size of scientific sensing solutions must be further reduced for a wearable monitoring system. MDPI 2022-01-06 /pmc/articles/PMC8780031/ /pubmed/35062385 http://dx.doi.org/10.3390/s22020425 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Xue, Yirui
Thalmayer, Angelika S.
Zeising, Samuel
Fischer, Georg
Lübke, Maximilian
Commercial and Scientific Solutions for Blood Glucose Monitoring—A Review
title Commercial and Scientific Solutions for Blood Glucose Monitoring—A Review
title_full Commercial and Scientific Solutions for Blood Glucose Monitoring—A Review
title_fullStr Commercial and Scientific Solutions for Blood Glucose Monitoring—A Review
title_full_unstemmed Commercial and Scientific Solutions for Blood Glucose Monitoring—A Review
title_short Commercial and Scientific Solutions for Blood Glucose Monitoring—A Review
title_sort commercial and scientific solutions for blood glucose monitoring—a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780031/
https://www.ncbi.nlm.nih.gov/pubmed/35062385
http://dx.doi.org/10.3390/s22020425
work_keys_str_mv AT xueyirui commercialandscientificsolutionsforbloodglucosemonitoringareview
AT thalmayerangelikas commercialandscientificsolutionsforbloodglucosemonitoringareview
AT zeisingsamuel commercialandscientificsolutionsforbloodglucosemonitoringareview
AT fischergeorg commercialandscientificsolutionsforbloodglucosemonitoringareview
AT lubkemaximilian commercialandscientificsolutionsforbloodglucosemonitoringareview